Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808833 · ClinicalTrials.gov registry record
Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01808833: Clinical Trial study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT01808833 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808833 was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.
Primary Outcome
Validated frailty measures, and geriatric assessment tools will be used.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-11 |
Why NCT01808833 stopped before completion
NCT01808833 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01808833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01808833 about?
NCT01808833 is a clinical study titled "Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy". The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.
What is the current status of trial NCT01808833?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2012-02. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01808833?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia